The Importance of Chest CT Scan in COVID-19 by Tenda, Eric Daniel et al.
CASE  REPORT
68 Acta Med Indones - Indones J Intern Med • Vol 52 • Number 1 • January 2020
The Importance of Chest CT Scan in COVID-19: A Case Series
Eric D. Tenda1,2, Mira Yulianti1, Moses M. Asaf1, Reyhan E. Yunus3,  
Wita Septiyanti3, Vally Wulani3, Ceva W. Pitoyo1, Cleopas M. Rumende1,  
Siti Setiati4
1 Division of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine Universitas 
Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
2 National Heart and Lung Institute, Imperial College London, United Kingdom.
3 Departement of Radiology, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, 
Jakarta, Indonesia.
4 Division of Geriatric Medicine, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia 
- Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Corresponding Author:
Eric Daniel Tenda, MD. National Heart and Lung Institute, Imperial College London. South Kensington Campus, 
London, Greater London SW7 2AZ, United Kingdom. email: ericdanieltenda@yahoo.com.
ABSTRAK
Coronavirus disease 2019 (COVID-19) adalah penyakit pernapasan akut yang sangat menular yang 
disebabkan oleh Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2), sebuah beta coronavirus 
yang pertama kali ditemukan di Wuhan, Cina, pada akhir 2019. COVID-19 telah menyebar dengan cepat secara 
global, dan pada Maret 2020, telah secara resmi dinyatakan sebagai pandemi oleh World Health Organization 
(WHO). Salah satu tantangan dalam mengelola COVID-19 adalah identifikasi modalitas diagnostik yang cepat, 
mudah diakses, dan terpercaya yang dapat berfungsi sebagai alternatif untuk pemeriksaan reverse-transcriptase 
polymerase chain reaction (RT-PCR). Saat penulisan makalah ini, RT-PCR masih merupakan pemeriksaan yang 
direkomendasikan dalam mendiagnosis COVID-19, tetapi gagasan tentang alat diagnostik yang lebih cepat 
dan akurat adalah kemungkinan yang layak untuk diteliti. Tujuan dari studi kasus ini adalah untuk menyelidiki 
kepentingan dan kefaedahan chest computed tomography (CT) dalam diagnosis COVID-19, karena semakin 
banyak bukti yang memberi kesan bahwa chest CT dapat terbukti berguna dalam jalur klinis diagnosis COVID-19.
Kata kunci: respiratory medicine, radiologi, ilmu penyakit dalam.
ABSTRACT
The coronavirus disease 2019 (COVID-19) is a highly transmissible acute respiratory disease that is caused 
by the Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2), a beta coronavirus first discovered in 
Wuhan, China, in late 2019. COVID-19 has been spreading swiftly globally, and as of March 2020, has been 
officially declared a pandemic by the World Health Organization (WHO). One of the challenges in managing 
COVID-19 is the identification of a swift, accessible, and reliable diagnostic modality that could serve as an 
alternative to reverse-transcriptase polymerase chain reaction (RT-PCR). As of the writing of this paper, RT-PCR 
is still the recommended tool in diagnosing COVID-19, but the notion of a more prompt and accurate diagnostic 
tool is a possibility worth looking into. The objective of this case study is to investigate the importance and utility 
of chest computed tomography (CT) in the diagnosis of COVID-19, as increasing pieces of evidence suggest that 
chest CT could prove useful in the clinical pathway in diagnosing COVID-19.
Keywords: respiratory medicine, radiology, internal medicine.
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INTRODUCTION
Severe Acute Respiratory Syndrome 
CoronaVirus-2 (SARS-CoV-2) is a beta 
coronavirus that induces an acute respiratory 
disease called the coronavirus disease 2019 
(COVID-19) by binding into the angiotensin-
converting enzyme 2 (ACE2) receptor of 
humans.1 Since its discovery in China in early 
January 2020, it has been spreading aggressively 
and globally at an alarming rate. On March 2, 
2020, the first case of COVID-19 in Indonesia 
(Depok, West Java) was announced by the 
President of the Republic of Indonesia. Since 
then, COVID-19 has been spreading swiftly 
throughout Indonesia, with the epicentre of the 
disease being in Jakarta, the most populated city 
and the capital of Indonesia. As of April 9, 2020, 
2,761 confirmed cases of COVID-19 with 280 
fatalities had been reported in Indonesia. The 
World Health Organization (WHO) recommends 
suspected cases to be screened for the virus with 
nucleic acid amplification tests (NAAT), such as 
reverse-transcriptase polymerase chain reaction 
(RT-PCR).2 However, recent studies have 
highlighted the potential importance of chest 
computed tomography (CT) in the screening 
and diagnosis of COVID-19. Chest CT has been 
suggested to possess the potential to diagnose 
COVID-19 with significant sensitivity, and even 
screen asymptomatic patients.3-5 This case series 
will explore the suggested potential of chest CT 
and its utility for COVID-19.
CASE ILLUSTRATION
The first patient is a 52-year-old male that 
came into the emergency unit of a general 
hospital in Central Jakarta, Indonesia, with a five-
day history of subjective fever, which worsens 
during the afternoon or night, and diarrhoea at 
the start of the onset of the illness. The presence 
of active cough, expectoration and dyspnea were 
denied by the patient. The patient disclosed that 
he had no contact with suspected or confirmed 
COVID-19 patients other than his wife - who had 
symptoms of dry cough but no fever - and had 
been working from home two weeks prior to the 
onset of his illness. The patient had limited his 
contact with other people, but he still routinely 
went to a local mosque for prayer. The patient 
had a history of grade I hypertension (JNC VIII), 
controlled by daily consumption of angiotensin 
receptor blocker. Physical evaluation by the 
physician showed relative bradycardia, a fever 
of 38.2°C, coated tongue, and absent rhonchi 
on bilateral pulmonary auscultation. Saturation 
measured using pulse oximetry was 97-99% in 
room atmosphere. Tubex®TF rapid typhoid test 
was conducted, and the result was +10 (strong 
positive). Laboratory results on admission 
reflected a decrease in white blood count (WBC), 
platelets, and eosinophil, a minor increase in 
D-dimer, and a significant increase in C-reactive 
protein (CRP). Chest X-ray (CXR) showed 
vague signs of bilateral pericardial infiltrate, 
suggestive of pneumonia. Chest CT was 
subsequently suggested to confirm the findings of 
CXR. Non-contrast chest CT showed peripheral 
ground-glass opacities and interlobular septal 
thickening in almost all segments of both lungs, 
suggestive of interstitial pneumonia. RT-PCR test 
using specimens taken from oropharyngeal and 
nasopharyngeal swabs were positive for SARS-
CoV-2. The first patient was discharged after 11 
days of hospitalization.
The second patient is a 37-year-old male that 
came into the emergency unit of a general hospital 
in Central Jakarta, Indonesia, with a three-day 
history of subjective fever, dry cough, sore 
throat, and a mild shortness of breath. The patient 
disclosed that he had not travelled anywhere in 
the month prior to the onset of illness, but he was 
still working in his office right until the disease 
manifested. The patient worked in the import 
and export division where he met with many 
foreign co-workers that came and went out of the 
country and suggested that he might have been 
infected by a foreigner that had been confirmed 
for COVID-19. Physical evaluation showed 
stable vital signs, except a fever of 38.5°C, and 
bilateral rhonchi on the basal region of the lungs. 
Saturation measured using pulse oximetry was 
98% with 3 LPM flow oxygen supplementation 
delivered using nasal cannula. Laboratory results 
on admission reflected a significant increase 
in AST and CRP, while procalcitonin levels 
are normal. Differential blood count showed 
minor lymphocytopenia and a minor increase in 
segmented neutrophil. CXR showed infiltrates 
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in the middle segment of both lungs, suggestive 
of pneumonia. Non-contrast chest CT showed 
multiple consolidated areas, with ground-glass 
opacities and interlobular septal thickening in all 
segments of both lungs with random distribution 
(suggestive of pneumonia), and multiple 
mediastinum lymphadenopathy. RT-PCR test 
using specimens taken from oropharyngeal and 
nasopharyngeal swabs were positive for SARS-
CoV-2. The second patient was discharged after 
12 days of hospitalization.
The third patient is a 57-year-old male that 
came into the emergency unit of a public hospital 
in West Jakarta, Indonesia, with a 5-day history 
of fever, malaise, and headache. The presence 
of active cough, expectoration, and dyspnea 
were denied. The patient is a doctor who works 
at a private clinic and suggested that he might 
have been infected during his daily practice 
by a possible COVID-19 patient. Physical 
evaluation by the physician showed nothing out 
of the ordinary and stable vital signs, except 
for a fever of 38.8°C. Saturation measured 
using pulse oximetry was 98-99% in room 
atmosphere. Laboratory results on admission 
reflected a minor increase in procalcitonin levels 
and an increase in ALT. Differential blood count 
showed lymphocytopenia and an increase in 
segmented neutrophil. CXR showed bilateral 
pericardial pneumonic infiltrate, suggestive of 
pneumonia. Chest CT showed subpleural ground 
glass opacity with interlobular septal thickening. 
COVID-19 antibody rapid test was conducted at 
admission and the result was negative for both 
IgM and IgG. RT-PCR specimens were taken 
from oropharyngeal and nasopharyngeal swabs 
during admission, but the results are yet to be 
produced. The third patient was discharged after 
14 days of hospitalization.
X-ray and CT Scan
The x-ray equipment used in this case series 
was Polymobil Plus Mobile X-ray (Siemens 
Healthineers, Erlangen, Germany). Chest X-ray 
images were taken on AP supine projection 
with exposure factors of 100-110 kVp and 
4-8 mAs. The CT equipment used in this case 
series was SOMATOM Definition AS 64 slices 
(Siemens Healthineers, Erlangen, Germany) with 
parameters of 120 kV, 124 mAs, and 5 mm image 
thickness continued with lung and mediastinum 
window reconstruction. Images were sent to 
INFINITT PACS (INFINITT Healthcare, Korea) 
to be read by the radiologists. Senior radiologists 
with practical experience of 20 years provided 
expertise for both CXR and chest CT images of 
each patient.
The patients in this case series were all males 
with an age range of 37-57 years old. All three 
had mild to moderate symptoms with the most 
Figure 1. Radiological findings of the first patient. (a). CXR, 
vague bilateral peripheral ground-glass opacity infiltrates; 
(b). Chest CT (transverse), bilateral peripheral ground-glass 
opacity with interlobular septal thickening.
Figure 2. Radiological findings of the second patient. (a). 
CXR, bilateral ground-opacity in the peripheral section of 
the lungs, suggestive of pneumonia; (b). Chest CT (coronal), 
bilateral peripheral ground-glass opacity and multiple 
consolidated areas with interlobular septal thickening.
Figure 3. Radiological findings of the third patient. (a). 
CXR, bilateral pericardial pneumonic infiltrate; (b). Chest CT 
(transverse), subpleural ground glass opacity with interlobular 
septal thickening.
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common symptom being fever. Two out of the 
three patients had lymphocytopenia, while only 
the first patient had decreased white blood count 
and platelets. The first and second patient had a 
significantly high level of CRP, especially the 
second patient with CRP levels of approximately 
20 times over the normal range. The CXR of 
all three patients showed bilateral infiltrates, 
suggestive of pneumonia. Chest CT of all three 
patients showed bilateral subpleural ground-
Table 1. Baseline characteristics of COVID-19 patients
Patient 1 Patient 2 Patient 3 Reference range
Sex Male Male Male
Age 42 37 57
Comordibities HT gr I No No
Travel history No No No
Symptoms
 - Fever P P P
 - Cough x P x
 - Expectoration x x x
 - Malaise x x P
 - Headache x x P
 - Dyspnea x P x
 - Nausea/vomiting x x x
 - Diarrhoea P x x
Lab Results
 - Haemoglobin (g/dL) 13.2 15.3 14.5 13.0 – 17.0
 - Thrombocyte (103/mL) 85 191 191 150 - 410
 - Leukocyte (103/mL) 3.09 8.20 5.32 4.00 – 10.00
 - Lymphocytes (%) 28.5 13 13 20 - 40
 - Hs-CRP (mg/L) 16.1 100 No data <5.0
 - D-dimer (mg/L) 520 No data No data 0 - 500
 - Procalcitonin (ng/mL) No data 0.21 0.18 <0.05
 - PT (sec) 12 No data No data 9 - 13
 - aPTT (sec) 33.3 No data No data 25.0 – 36.5
 - Ureum (mg/dL) 40 15.7 25 19 - 44
 - Creatinine (mg/dL) 0.90 0.90 0.90 0.73 – 1.18
 - AST (U/L) 20 95 34 5.00 – 34.00
 - ALT (U/L) 16 36 52 0.00 – 55.00
 - O2 saturation 99% 98% with 3 LPM O2 99% 97-100%
Table 2. Chest X-ray and Chest CT findings of COVID-19 patients
Patient 1 Patient 2 Patient 3
Chest X-ray
 - Unilateral Infiltrate X X X
 - Bilateral infiltrate P P P
Chest CT
 - Ground-glass opacity P P P
 - Bilateral consolidation P P P
 - Interlobular septal thickening P P P
 - Pleural effusion X X X
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glass opacity with interlobular septal thickening, 
also suggestive of pneumonia. RT-PCR for the 
first and second patient was confirmed positive 
for SARS-CoV-2. As of the writing of this paper, 
the RT-PCR result of the third patient is yet to be 
released. The mean duration of hospitalization 
was 12.3 days.
DISCUSSION
To our knowledge, as of the writing of this 
paper, this is the first case series in Indonesia 
that discusses the importance of chest CT in 
diagnosing COVID-19. The median age in 
this study was 42 years old, which is younger 
than that reported by Guan et al.6 (47 years 
old), Wang et al.7 (56 years old), Zhou et al.8 
(56 years old), and Zhang et al.9 (57 years 
old). In accordance with recent studies, the 
most common clinical symptom in this report 
was fever, while gastrointestinal symptoms 
only appeared in one patient in the form of 
early onset diarrhoea.6-9 However, out of the 
three patients, only one manifested dry cough, 
which, in tandem with fever, were the two most 
dominant clinical characteristics as reported by 
several recent studies.6-9 All three patients had 
mild to moderate symptoms, most likely due to 
their relatively young age, with the oldest patient 
being 57 years old. Studies have shown that older 
patients tend to manifest more severe symptoms, 
while younger patients tend to manifest mild to 
moderate symptoms.7-10 The mean duration of 
hospitalization was 12.3 days, quite similar to 
the data reported by Guan et al.6 (12.8 days), 
and Zhou et al.8 (11.0 days). The patients 
were discharged based on clinical, laboratory, 
and radiological improvements. Ideally, two 
consecutive negative RT-PCR results should be 
the decisive factor in the discharge of COVID-19 
patients. However, due to the continually 
increasing number of confirmed patients, and 
limited access to RT-PCR results, physicians 
adapted and discharged patients based on the 
improvements of the patients’ general conditions 
and minimalized the chance of transmission by 
monitoring the number of days since the first 
onset of their illness.
Although the three patients manifested 
different clinical symptoms that are mostly mild 
and different laboratory findings that are not 
specifically indicative of COVID-19, all three 
chest CT scans had uniformed results which 
point to the diagnosis of COVID-19. Physicians 
should be aware and not be misled by vague 
laboratory findings of the patients. Such as in 
the case of the first patient, where the Tubex®TF 
rapid typhoid test even suggested a strong 
positive result for typhoid. The patient received 
antibiotics prescribed for typhoid, but the fever 
persisted, and CRP levels kept increasing. Only 
after the patient received a new therapy regiment 
(Hydroxychloroquine 2 x 400mg, Azythromycin 
1 x 500mg, Vitamin C 2 x 2000mg) did the fever 
subside and CRP levels started decreasing. To 
the authors’ knowledge, there is no study yet 
reporting a false positive for Salmonella sp. IgM 
in COVID-19 patients.
The chest CT findings in this case series were 
largely consistent with those found in recent 
studies, with the hallmark of novel coronavirus 
pneumonia (NCP) being the presence of a bilateral 
subpleural distribution of ground-glass opacity 
accompanied by interlobular septal thickening.5,11 
All three patients had positive chest CT findings 
for COVID-19 before RT-PCR confirmed the 
diagnosis a few days after, indicating that chest 
CT is a swift screening tool for COVID-19. 
Moreover, chest CT has also been exhibited to 
be able to diagnose COVID-19 accurately, with 
a sensitivity of over 97% and a specificity of 
approximately 25%.(3, 4) The study of Fang 
et al. has even argued that chest CT is a more 
reliable alternative to RT-PCR in diagnosing 
COVID-19 patients, due to various variables 
that could potentially render the results of RT-
PCR invalid.4 While Shi et al.5 proposed that 
chest CT could be used to screen asymptomatic 
COVID-19 patients, the study of Ai et al.3 has 
suggested that there is a mean delay of around 5 
days for serial RT-PCR test to turn from initial 
negative to positive. As a delay in diagnosis 
could translate into a delay in proper patient 
management, a swift and accurate diagnostic 
tool is desperately needed, especially in a 
pandemic such as this. Nevertheless, as essential 
of a modality CT is, the safety and health of the 
radiographers, radiologists, healthcare workers 
and patients are of the utmost importance, as per 
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the current statement from the American College 
of Radiology. Therefore, precautionary steps 
should be taken to limit the spread of COVID-19 
and to ensure minimal radiation exposure to both 
patients and healthcare workers.
The authors are aware that there are still 
limitations to this study. First, the population of 
this study was small, and might not represent 
a genuine condition in a natural environment. 
The inclusion of more patients would naturally 
paint a more comprehensive picture of the 
importance of chest CT findings in COVID-19 
patients. Second, this study only fixated on the 
baseline chest CT findings that the physicians 
first encountered, without including findings 
from follow-up CT scans. The inclusion of 
follow-up CT scans could potentially highlight 
the importance of chest CT in following disease 
progression. Third, this study only included the 
baseline laboratory results of the patients on 
admission, excluding other laboratory exams 
that the physicians initially deemed unnecessary 
before the confirmation of the diagnosis of 
COVID-19. More comprehensive laboratory 
findings could give a more vivid understanding 
of the overall condition of the patients, and 
insight to prognosis.
CONCLUSION
From this case series, we highly suggest 
the use of non-contrast chest CT to diagnose 
COVID-19 in patients showing moderate 
symptoms with any vague findings from chest 
x-ray despite a negative outcome for RT-PCR. 
The decision to use CT to confirm inconclusive 
findings from chest x-ray should be deliberately 
taken by the responsible physician based on 
established clinical pathways and guidelines.
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